Now that's some PHENOMENAL DD! Your giving Dr. Gwinis a run for his money!
I did a little more digging around and not only found 1 corporate presentation but an additional one as well. Now the first one I am going to post has a date of August 2019. When the viewers at home read it you will find there a few considerable differences.
Now lets play connect the dots GCAN & SYMTOMAX version
The Company has finalized and executed a definitive agreement with Symtomax, a leading licensed cannabis cultivation company with the largest outdoor grow facilities in Europe. Symtomax has a number of agreements in place with European government health ministries to manufacture and distribute cannabidiol products through their health systems. Pending finalization of regulatory approvals, we expect this to start yielding revenue in the form of royalty payments for Greater Cannabis in year one of commercialization based on current timing projections. Further opportunities in Africa are being explored in parallel.